Skip navigation
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
Prevention Among Injection Drug Users
 IDU HIV Prevention

Archive archive

 IDU Home
 Fact Sheets:
 Syringe Disinfection
 Sterile Syringes
 Viral Hepatitis
 Subst. Abuse
Treatment
 Criminal Justice
 Order Printed Materials
 Dear Colleague Letters
 Other Publications
 Comprehensive
Approach
 Brochure
 Document
 Safe Community Syringe Disposal
Explore IDU Topics
Comments
  Legend
Link to a PDF document Link to a PDF document
Link to a Non-CDC site
Link to non-CDC site or document and does not necessarily represent the views of CDC
Adobe Acrobat (TM) Reader needs to be installed on your computer in order to read documents in PDF format. Download the Reader.
U.S. Department of Health and Human Services

Archival Content: 1999-2005

A Comprehensive Approach:
Preventing Blood-Borne Infections Among Injection Drug Users


Chapter 3, Section 5: References

Academy for Educational Development (AED). Comprehensive HIV prevention services for injection drug users: an assessment of state and local technical assistance issues and priorities. Washington (DC): AED; August 1999. Prepared for the Centers for Disease Control and Prevention.

Ary DV, Duncan TE, Biglan A, Metzler CW, Noell JW, Smolkowski K. Development of adolescent problem behavior. Journal of Abnormal Child Psychology 1999;27(2):141-150.

Belenko S. Behind bars: substance abuse and America's prison population. New York: National Center on Addiction and Substance Abuse at Columbia University (CASA); January, 1998. www.casacolumbia.orgLink to a Non-CDC Link

Berger JM, Levin SM. Adolescent substance abuse and HIV/AIDS: linking the systems. Journal of Adolescent Chemical Dependency 1993;2(3/4):49-56.

Booth RE, Kwiatkowski CF, Weissman G. Health-related service utilization and HIV risk behaviors among HIV infected drug users and crack smokers. Drug and Alcohol Dependence 1999;55(102):69-78.

Botvin GJ, Baker E, Dusenbury L, Botvin EM, Diaz T. Longterm followup results of a randomized drug abuse prevention trial in a white middle-class population. JAMA 1995a;273(14):1106-1112.

Botvin GJ, Baker E, Filazzola AD, Botvin EM. A cognitive-behavioral approach to substance abuse prevention: one-year follow-up. Addictive Behaviors 1990;15(1):47-63.

Botvin GJ, Schinke SP, Epstein JA, Diaz T, et al. Effectiveness of culturally focused and generic skills training approaches to alcohol and drug abuse prevention among minority adolescents: two-year followup results. Psychology of Addictive Behaviors 1995b;9(3):183-194.

Bry BH, Catalano RF, Kumpfer KL, Lochman JE, Szapocznik J. Scientific findings from family prevention intervention research.Link to a Non-CDC Link In: Ashery RS, Robertson ED, Kumpfer KL, editors. NIDA Research Monograph 177: drug abuse prevention through family interventions. Rockville (MD): National Institute on Drug Abuse; 1998. NIH Publication No.:97-4135.

Calsyn DA, Meinecke C, Saxon AJ, Stanton V. Risk reduction in sexual behavior: a condom give away program in a drug abuse treatment clinic. American Journal of Public Health 1992;82(11):1536-1538.

Calzavara L, et al. Understanding HIV-related risk behavior in prison: the inmates perspective. Toronto: University of Toronto, Faculty of Medicine, HIV Social, Behavioral and Epidemiological Studies Unit; 1997.

Centers for Disease Control and Prevention/AIDS Community Demonstration Projects Research Group (CDC/ACDP). Community-level HIV intervention in five cities: final outcome data from CDC AIDS Community Demonstration Projects. American Journal of Public Health 1999;89(3):336-345.

Centers for Disease Control and Prevention (CDC). Hepatitis B fact sheet. June 1999.

Centers for Disease Control and Prevention (CDC). Dangerous intersection of drug use and sexual HIV transmission points to critical need for comprehensive HIV prevention among drug users. 1998a. www.cdc.gov/hiv/pubs/facts/idu.htm

Centers for Disease Control and Prevention (CDC). Update: HIV counseling and testing using rapid tests - United States, 1995. Morbidity and Mortality Weekly Report 1998b Mar 27;47(11):211-215.

Centers for Disease Control and Prevention (CDC). Continued sexual risk behavior among HIV-seropositive drug-using men-Atlanta; Washington, DC; San Juan, Puerto Rico, 1993. Morbidity and Mortality Weekly Report 1996;45:151-152.

Centers for Disease Control and Prevention (CDC). Counseling and testing intravenous-drug users for HIV infection-Boston. Morbidity and Mortality Weekly Report 1989 Jul 21;38(28):489-90, 495-496.

Chu A, Torbert A, Brown A, Ellison J, Matthew I, McFarland J, Forlenza S. Overlapping AIDS epidemic among injecting drug use (IDU) and heterosexual exposure (HT) in New York City (NYC) AIDS cases. 1998; 5th Conference on Retrovirology and Opportunistic Infections, February 1-5. P.103 (Abstract No. 129).

Cohen A, Kibel B, Stewart K. DHHS Publication No.(SMA) 95-3033. Rockville (MD): Substance Abuse and Mental Health Guidelines and Benchmarks for Precaution Programming Administration; 1997.

Corby NH, Rhodes F, Wolitski RJ. Substance use and sexual behavior among gay/bisexual men at an alternative test site. IV International Conference on AIDS, Stockholm, Sweden; 1988.

Des Jarlais DC, Hagan H, Friedman SR, Friedmann P, Goldberg D, Frischer M, Green S, Tunving K, Ljungberg B, Wodak A, et al. Maintaining low HIV seroprevalence in populations of injection drug users. JAMA 1995; 274:1226-1231.

Dishion T J, Kavanagh K, Kiesner J. Prevention of early adolescent substance abuse among high-risk youth: a multiple gating approach to parent intervention.Link to a Non-CDC Link In: Ashery RS, Robertson ED, Kumpfer KL, editors. NIDA Research Monograph 177: drug abuse prevention through family interventions. Rockville (MD): National Institute on Drug Abuse; 1998. NIH Publication No.: 97-4135.

Dolan KA, et al. A network of HIV infection among Australian inmates. Poster abstract no. We.D.3655, presented at the 11th International Conference on AIDS, Vancouver, July 10, 1996.

Donaldson SI, Graham JW, Hansen WB. Testing the generalizability of intervening mechanism theories: understanding the effects of adolescent drug use prevention interventions. Journal of Behavioral Medicine 1994;17(2):195-216.

Donovan JE, Jessor R, Costa FM. Syndrome of problem behavior in adolescence: a replication. Journal of Consulting and Clinical Psychology 1988;56(5):762-765.

Drug Strategies. Making the grade: a guide to school drug prevention programs.Link to a Non-CDC Link Washington (DC): Drug Strategies, 1999.

Edlin BR, Irwin KL, Faruque S, McCoy CB, Word C, Serrano Y, Inciardi JA, Bowser BP, Schilling RF, Holmberg SD. Intersecting epidemics: crack cocaine use and HIV infection among inner-city adults. New England Journal of Medicine 1994;331(21):1422-1427.

Eggert LL, Thompson EA, Herting JR Nicholas LJ. Reducing suicide potential among high-risk youth: tests of a school-based prevention program. Suicide and Life-Threatening Behavior 1995;25(2):276-296.

Eggert LL, Thompson EA, Herting JR, Nicholas LJ, Dicker BG. Preventing adolescent drug abuse and high school dropout through an intensive school-based social network development program. American Journal of Health Promotion 1994;8(3):202-215.

El-Bassel N, Schilling RF. 15-month follow-up of women methadone patients taught skills to reduce heterosexual HIV transmission. Public Health Reports 1992;107(5):500-504.

Epstein J, Gfroerer J. Changes affecting NHSDA estimates of treatment need for 1994-1996.Link to a Non-CDC Link Office of Applied Studies, Substance Abuse and Mental Health Services Administration (SAMHSA); January 14, 1998.

Farrell AD, Danish SJ, Howard CW. Relationship between drug use and other problem behaviors in urban adolescents. Journal of Consulting and Clinical Psychology 1992;60:705-712.

Friedman SR, Curtis R, Neaigus A, Jose B, Des Jarlais DC. Social networks, drug injectors's lives, and HIV/AIDS. New York: Kluwer/Plenum Press; 1999.

Friedman SR, Des Jarlais DC, Ward TP. Social models for changing health-relevant behavior. In: DiClemente R, Peterson J, editors. Preventing AIDS: theories and methods of behavioral interventions. New York: Plenum Press; 1994; pp. 95-116.

Friedman SR, Des Jarlais DC, Ward TP, Jose B, Neaigus A, Goldstein M. Drug injectors and hetero sexual AIDS. In: Sherr L, editor. AIDS and the heterosexual population, Chur (Switzerland): Harwood Academic Publishers; 1993; pp.41-65.

Gerstein DR, Harwood HJ, editors. Treating drug problems. Vol. I: A study of the evolution, effectiveness, and financing of public and private drug treatment systems. Washington (DC): National Academy Press; 1990.

Goldberg L, Elliot D, Clarke GN, MacKinnon DP, Moe E, Zoref L, Green C, Wold SL, Greffrath E, Miller DJ, Lapin A. Effects of a multidimensional anabolic steroid prevention intervention: the ATLAS (Adolescents Training and Learning to Avoid Steroids) program. JAMA 1996a;276:1555-1562.

Goldberg L, Elliot DL, Clarke GN, MacKinnon DP, Zoref L, Moe E, Green C, Wolf S. The Adolescents Training and Learning to Avoid Steroids (ATLAS) prevention program: background and results of a model intervention. Archives of Pediatric and Adolescent Medicine 1996 b;150:713-721.

Gostin LO. The legal environment impeding access to sterile syringes and needles: the conflict between law enforcement and public health. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998;18(Suppl 1):S60-S70.

Groseclose SL, Weinstein B, Jones T S, Valleroy LA, Fehrs LJ, Kassler W J. Impact of increased legal access to needles and syringes on the practices of injecting-drug users and police officers-Connecticut, 1992-93. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1995;10:82-89.

Hammett TM, Harmon P, Maruschak LM. 1996-1997 Update: HIV/AIDS, STDs, and TB in correctional facilities. Issues and Practices in Criminal JusticePDF IconLink to a Non-CDC Link (562 KB, 107 pages) (National Institute of Justice 176344); July, 1999.

Hawkins JD, Catalano RF, Miller JY. Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention. Psychological Bulletin 1992;112(1):64-105.

Health Resources and Services Administration (HRSA). Evaluation of the effects of Ryan White Title I funding on services for HIV-infected drug abusers, baseline data. Year 1: summary report. Rockville (MD): HRSA; August, 1994. www.hab.hrsa.gov/publications.htmlLink to a Non-CDC Link

Hubbard RL, Marsden ME, Rachal JV, Harwood HJ, Cavanaugh ER, Ginzburg HM. Drug abuse treatment: a national study of effectiveness. Chapel Hill (NC): University of North Carolina Press; 1989.

Keenan JM. Summary of research agenda. In: Conference proceedings of the Agency for Health Care Policy and Research (AHCPR) community based care of persons with AIDS: developing a-research agenda.Rockville (MD): U.S. Department of Health and Human Services, Public Health Service; 1990; pp.169-172.

Kumpfer KL, Molraard V, Spoth R. The "Strengthening Families Program" for the prevention of delinquency and drug use. In: Peters R, McMahon R, editors. Preventing childhood disorders, substance abuse, and delinquency. Thousand Oaks (CA): Sage Publications; 1996.

Kwiatkowski CF, Booth RE. HIV-seropositive drug users and unprotected sex. AIDS and Behavior 1998;2(2):151-159.

Lauby JL, Smith PJ, Start M, Person B, Adams J. A community-level HIV prevention intervention for inner-city women: results of the Women and Infants Demonstration Projects. American Journal of Public Health 2000;90(2):216-222.

Levy JA, Fox SE. The outreach-model of partner notification with IDUs. Public Health Reports 1998;113(Suppl 1):160-169.

Lurie P, Jones TS, Foley J. A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution? Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998;18(Suppl 1):S45-S51.

Malow RM, West JA, Corrigan SA, Pena JM, Cunningham SC. Outcome of psychoeducation for HIV risk reduction. AIDS Education and Prevention 1994;6(2):113-125.

Mahon N. New York inmates' HIV risk behaviors: the implications for prevention policy and programs. American Journal of Public Health 1996;86:1211-1215.

McCusker J, Stoddard AM, Zapka JG, Zorn M. Use of condoms by heterosexually active drug abusers before and after AIDS education. Sexually Transmitted Diseases 1993;20(2):81-88.

Metsch L, McCoy C, Lai S, Miles C. Continuing risk behaviors among HIV-seropositive chronic drug users in Miami, Florida. AIDS and Behavior 1998;2(2):161-169.

Metzger DS, Navaline H, Woody GE. Drug abuse treatment as AIDS prevention. Public Health Reports 1998;113(Suppl1):97-106.

National Alliance of State and Territorial AIDS Directors (NASTAD). HIV prevention and access to sterile syringes.PDF IconLink to a Non-CDC Link (34 KB, 2 pages) Joint statement issued by the American Medical Association (AMA), American Pharmaceutical Association (APhA), Association of State and Territorial Health Officials (ASTHO), National Association of Boards of Pharmacy (NABP), National Alliance of State and Territorial AIDS Directors (NASTAD); October 1999.

National Institutes of Health (NIH). Effective medical treatment of opiate addiction.Link to a Non-CDC Link NIH Consensus Statement Online. Bethesda (MD): NIH; 1997a, Nov 17-19;15(6):1-38.

National Institutes of Health (NIH). Interventions to prevent HIV risk behaviors.Link to a Non-CDC Link NIH Consensus Statement Online. Bethesda (MD): NIH; 1997b, Feb 11-13;15(2):1-41.

National Institute on Drug Abuse (NIDA). Principles of drug addiction treatment: a research-based guide.Link to a Non-CDC Link Rockville (MD): NIDA; 1999. NIH Publication No. 99-4180.

National Institute on Drug Abuse (NIDA). Preventing drug use among children and adolescents: a research-based guide.Link to a Non-CDC Link Rockville (MD): NIDA; 1997. NIH Publication No. 97-4212.

New York Harm Reduction Educators, Inc. (NYHRE). Harm reduction training part 1: drug users, drug using behavior and service delivery. A report produced for the New York State AIDS Institute, November, 1998.

O'Brien CP, McLellan AT. Myths about the treatment of addiction. Lancet 1996;347:237-240.

Osgood DW, Johnston LS, O'Malley PM, Bachman JG. The generality of deviance in late adolescence and early adulthood. American Sociological Review 1988;53:81-93.

Pentz MA. The school-community interface in comprehensive school health education. In: Stansfield S, editor. 1996 Institute of Medicine Annual Report, Committee on Comprehensive School Health Programs.Institute of Medicine. Washington (DC): National Academy Press; 1995.

Pentz MA, Dwyer JH, MacKinnon DP, Glay BR, Hansen WB, Wang EY, Johnson CA. A multi-community trial for primary prevention of adolescent drug abuse: effects on drug use prevalence. JAMA 1989;261:3259-3266.

Pickens RW, Leuke feld CG, Schuster CR, editors. NIDA Research Monograph 106: improving drug abuse treatment. Rockville (MD): National Institute on Drug Abuse; 1991 DHHS Publication No. (ADM) 91-1754; NTIS PB#92-105873.

Remis RS, Bruneau J, Hankins CA. Enough sterile syringes to prevent HIV transmission among injection drug users in Montreal? Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998;18(Suppl 1):S57-S59.

Rogers SJ, Tross S, Doino-Ingersol J, Weisfuse I. Partner notification with HIV- infected drug users: results of formative research. AIDS Care 1998;10(4):415-429.

Rusche S. Voluntary organizations. In: Coombs RH, Ziedonis DM, editors. Handbook on drug abuse prevention: a comprehensive strategy to prevent the abuse of alcohol and other drugs. Boston (MA): Allyn and Bacon; 1995. p. 181-195.

Spoth R. Family-focused prevention intervention research: a pragmatic perspective on issues and future directions.Link to a Non-CDC Link In: Ashery RS, Robertson ED, Kumpfer KL, editors. NIDA Research Monograph 177: drug abuse prevention through family interventions. Rockville (MD): National Institute on Drug Abuse; 1998. NIH Publication No.: 97-4135.

Strain EC, Bigelow GE, Liebson IA, Stitzer ML. Moderate- vs. high-dose methadone in the treatment of opioid dependence: a randomized trial.Link to a Non-CDC Link JAMA 1999;281:1000-1005.

Struckman-Johnson C, Struckman-Johnson D, Rucker L, Bumby K, Donaldson S. Sexual coercion reported by men and women in prison. Journal of Sex Research 1996;33:67-76.

Thaca I. One junkie's odyssey: drug users and the health care system.Link to a Non-CDC Link Harm Reduction Communications. New York (NY): New York Harm Reduction Educators, Inc.; Fall 1997.

Thiede H, Hagan H, Murrill CS. Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area. Journal of Urban Health 2000;77(3):331-345.

Valleroy LA, Weinstein B, Jones TS, Groseclose SL, Rolfs RT, Kassler WJ. Impact of increased legal access to needles and syringes on community pharmacies needle and syringe sales-Connecticut, 1992-1993. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1995;10(1):73-81.

Vanichseni S, Des Jarlais DC, Choopanya K, Friedmann P, Wenston J, Sonchai W, Sotheran JL, Raktham S, Carballo M, Friedman SR. Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, USA. AIDS 1993;7(6):887-891.

Wiebel WW, Jimenez A, Johnson W, Ouellet L, Jovanovic B, Lampinen T, Murray J, O'Brien MU. Risk behavior and HIV seroincidence among out-of-treatment injection drug users: a four-year prospective study. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1996;12(3):282-289.

   
View PDFPDF Icon

Previous Page | Table of Contents | Next Page

This CDC Web site is no longer being reviewed or updated and thus is no longer kept current. This site remains to assist researchers or others needing historical content.

   
Go to top

Privacy Policy | Accessibility

USA.gov: The U.S. Government's Official Web Portal